Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Egile nagusia: | Shawn, Ibna Hasan |
---|---|
Beste egile batzuk: | Jamiruddin, Mohd. Raeed |
Formatua: | Thesis |
Hizkuntza: | English |
Argitaratua: |
Brac University
2024
|
Gaiak: | |
Sarrera elektronikoa: | http://hdl.handle.net/10361/23931 |
Antzeko izenburuak
-
A review on Metastatic Melanoma combination therapy Ipilimumab-Nivolumab
nork: Chakraborty, Anupama
Argitaratua: (2024) -
Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
nork: Onanna, Kazi
Argitaratua: (2024) -
Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
nork: Rahman, Towsifur
Argitaratua: (2024) -
A review on combinatorial therapies in Melanoma
nork: Ahmmed, Md. Kawsar
Argitaratua: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
nork: Khandker, Tahia Anjum
Argitaratua: (2024)